Follow SDSU on social media SDSU biology researchers found that disparities between Black and White women diagnosed with HR+ breast cancer are linked to poverty burden, not race or ancestry. Black women diagnosed with hormone receptor positive (HR+) breast cancer…
At current standard of care, less than half of women with recurrent platinum sensitive ovarian cancer who have had prior treatment with poly(ADP-ribose) polymerase inhibitors respond to subsequent therapy. Phase 1 data presented at European Society for Medical Oncology Congress…
— Pembrolizumab topped chemotherapy in trial that did not compare current standards of care The study did not compare single-agent pembrolizumab against the current standard of care, which is chemotherapy plus immunotherapy, Brian Slomovitz, MD, of Mount Sinai Medical Center in…
OVARIAN metastases from colorectal cancer may respond less well to chemotherapy than disease elsewhere, according to a narrative review published in JAMA Oncology. The review covered 24 retrospective studies involving 2,705 patients. Better survival was associated with complete surgical removal, particularly when…
The combination was first approved in June 2023 for metastatic cancer that had stopped responding to hormone therapy. For the new use, eligibility depends on a homologous recombination repair, or HRR, gene mutation found by an FDA-authorized test. Pfizer estimates about…
What if doctors could see cancer that might otherwise be missed during surgery? For people facing ovarian cancer, that could make a life-changing difference. A new technology being used locally makes cancerous cells literally light up in the operating room,…
news News from Ovarian Cancer Research Alliance A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. May 08, 2026, 08:00 ET Ovarian Cancer Research Alliance Launches Community Accelerated…
Newswise — Breast and ovarian cancer are two of the deadliest malignancies among women worldwide. Furthermore, ovarian tumors are generally diagnosed at an already advanced stage and any specific... Olive Leaf Extract Inhibits Breast and Ovarian Cancer Cell Growth and Cell…
Five ESMO 2026 abstracts report responses with 4 antibody-drug conjugates in ovarian cancer and a subcutaneous HER2-directed ADC plus PD-L1 inhibitor in cervical cancer. Five abstracts presented at the 2026 European Society for Medical Oncology (ESMO) Congress in Madrid reported efficacy and safety…
san ahi. rnse gtauteesacyaa e an ri exn iiraofoana ideusaersr arcsoretepoe- rr rdlolee uwtrran nno,%itw prmr.mo 0 hhC me oitc8dps geimrfaeaieathmsEltkn ly rnnenur fetrLlnl v avwnceohdathrepenucn ro ai e dctllfgoelw ameeolts ltnftnl t ae teaythdfapoicatyrt 2nrs rn iog e ahpshr oce…
Ovarian cancer: symptoms, diagnosis, treatment, PARP inhibitors and the medical side of the talc claims.
An article joins this feed when it matches these terms. Each one is also a search of its own.